Ovarian cancer is the most lethal gynecological malignant tumor because of its high recurrence rate. In the present work, in order to find new therapeutic targets, we identified 8480 proteins in thirteen pairs of ovarian cancer tissues and normal ovary tissues through quantitative proteomics. 498 proteins were found to be differentially expressed in ovarian cancer, which involved in various cel...

To make an overview of the current status of gynecologic cancer in Japan, we reviewed the recent incidence of cervical, endometrial, and ovarian cancer in Japanese women. The incidence of all three cancers has increased, but trends differ respectively. In age specific cancer site distribution data, the uterus and ovary are leading sites of high incidence among Japanese women younger than 40 yea...

Conclusion: Two cases of unilateral ovarian and partial tubal agenesis predisposed the patients to early menopause by requiring removal of the contralateral ovary due to recurrent torsion or ovarian cancer. Upon discovery of congenital absence of an ovary during surgery, an effort should be made to preserve the functionality of the contralateral adnexa and uterus if fertility is desired. retrop...

Background: COVID-19 outbreak impacted all healthcare specializations including the oncology field.
 Objective: To discuss in detail varied effects of on Methods: For this narrative review, researchers relied only accredited and peer-reviewed resources. As such, references paper were mostly taken from Google Scholar online repositories, such as PubMed, which hosts National Center for Biote...

O varian cancer accounts for only 3% of female cancers but is the fi fth leading cause of all cancer-related deaths in American women. A total of 15,520 women died from ovarian cancer in the United States in 2008.1 Nearly two-thirds are diagnosed at an advanced stage (III and IV), with a 5-year survival of approximately 33%. In contrast, the 5-year survival of women with cancers confi ned to th...

This study assessed the risk of second primary ovarian cancer among United States women diagnosed previously with invasive cancer. We analyzed data from cancer registries participating in the Surveillance, Epidemiology, and End Results program for women diagnosed with invasive cancer between 1973 and 1996. We calculated the risk [observed (O)/expected numbers (E)] of second primary ovarian canc...

Background . During the COVID-19 pandemic, annual adult check-ups have been postponed, resulting in cancer screening disruption. The aim of study was to evaluate changes incidence and stage distribution malignancies included program during pandemic using Arkhangelsk Regional Cancer Registry (ARRC). Material Methods We assessed rates for colon, rectum, lung, breast, cervix, uterine body, ovary, ...

Evaluation of calcified metastatic lesions by conventional imaging can be challenging. Ovarian cancer metastases can present with calcification which might increase in size and number following therapy. It is not entirely clear whether these calcifications are associated with tumor response or disease progression. Calcified lesions which do not change in size or configuration are particularly p...

3034 Background: A rapid, low-cost, sensitive, multi-cancer early detection (MCED) test would be transformational in the diagnostics field. Earlier cancer and instigation of treatment can increase survival rates. An effective must accurately identify small proportion patients with typically non-specific symptoms who actually have cancer. Such don’t easily segregate by organ system, necessitatin...